Rocket


News + Filings
Transactions
Holdings


All
13F
13D/G
Other

Euclidean Capital LLC Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/14/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/15/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/16/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/14/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/14/2022 SC 13G/A Euclidean Capital LLC reports a 5.1% stake in PMV PHARMACEUTICALS, INC.
11/15/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
10/18/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/16/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
06/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/07/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
05/07/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
02/12/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/12/2021 SC 13G Euclidean Capital LLC reports a 9.3% stake in PMV PHARMACEUTICALS, INC.
09/29/2020 4 Euclidean Capital LLC (Former 10% Owner) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns: Converted 693,769 shares @ $0
Converted 2,601,637 shares @ $0
Converted 751,409 shares @ $0
Converted 132,601 shares @ $0
Converted 693,769 preferred shares @ $0
Converted 2,601,637 preferred shares @ $0
Converted 751,409 preferred shares @ $0
Converted 132,601 preferred shares @ $0
09/24/2020 3 Euclidean Capital LLC (10% Owner) has filed a Form 3 on PMV Pharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy